Table 2.
Number of reviews informing primary research
| CRG | Number of reviews | Type and number follow-on research | Review is cited a | Type of funder |
|---|---|---|---|---|
| Airways |
1 |
RCT |
Yes |
Not known |
| Bones, Joint and Muscle |
2 |
2 RCTs |
Yes |
Government (1 UK, 1 Australia) |
| Cystic Fibrosis |
5 |
5 RCTs |
Yes |
3 government (UK), 2 not known |
| Depression, Anxiety and Neurosis |
2 |
1 RCT, 1 not known |
1 Yes, 1 not known |
1 government (UK), 1 not known |
| Eyes and Vision |
1 |
1 Not known |
Yes |
1 charity |
| Incontinence |
3 |
3 RCTs |
2 Yes, 1 not known |
3 government (UK) |
| Injuries |
7 |
9 RCTs |
7 Yes, 2 not known |
7 government (3 Australia, 3 UK, 1 Denmark), 1 industry, 1 charity |
| Neuromuscular |
4 |
3 RCTs, 1 not known |
2 Yes, 2 not known |
2 government (1 USA, 1 France), 1 charity, 1 not known |
| Oral |
1 |
RCT |
Yes |
1 government (UK) |
| Pregnancy |
1 |
Qualitative |
Yes |
Not known |
| Schizophrenia |
1 |
1 RCT, 2 not known |
Not known |
Not known |
| Skin |
5 |
5 RCTs, 1 not known |
4 Yes, 2 not known |
3 government (UK), 2 charity (2 UK, 1 USA) |
| Tobacco Addiction | 2 | 3 RCTs | Yes (all) | 2 government (UK), 1 not known |
aThis relates to whether we found a study protocol or publication that cited the original Cochrane review.